Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Inhibrx Inc (INBX)

Inhibrx Inc (INBX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 921,273
  • Shares Outstanding, K 39,037
  • Annual Sales, $ 7,230 K
  • Annual Income, $ -81,770 K
  • 60-Month Beta 3.24
  • Price/Sales 132.55
  • Price/Cash Flow N/A
  • Price/Book 35.30
Trade INBX with:

Options Overview Details

View History
  • Implied Volatility 95.54% ( -0.37%)
  • Historical Volatility 105.63%
  • IV Percentile 29%
  • IV Rank 24.44%
  • IV High 222.32% on 06/06/22
  • IV Low 54.53% on 10/01/21
  • Put/Call Vol Ratio 0.08
  • Today's Volume 26
  • Volume Avg (30-Day) 91
  • Put/Call OI Ratio 11.18
  • Today's Open Interest 1,912
  • Open Int (30-Day) 740

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.87
  • Number of Estimates 1
  • High Estimate -0.87
  • Low Estimate -0.87
  • Prior Year -0.54
  • Growth Rate Est. (year over year) -61.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.14 +66.90%
on 07/13/22
25.52 -7.52%
on 08/09/22
+6.38 (+37.05%)
since 07/08/22
3-Month
7.67 +207.69%
on 06/16/22
25.52 -7.52%
on 08/09/22
+9.15 (+63.32%)
since 05/10/22
52-Week
7.67 +207.69%
on 06/16/22
47.90 -50.73%
on 11/02/21
-6.06 (-20.43%)
since 08/10/21

Most Recent Stories

More News
Inhibrx, Inc. (INBX) Reports Q2 Loss, Lags Revenue Estimates

Inhibrx, Inc. (INBX) delivered earnings and revenue surprises of -15.48% and 21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

INBX : 23.60 (-3.83%)
FULC : 7.76 (+4.86%)
Inhibrx Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights

/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development and a strong emerging pipeline, today reported...

INBX : 23.60 (-3.83%)
Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates

Guardant Health (GH) delivered earnings and revenue surprises of -80% and 4.11%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

GH : 53.08 (+8.42%)
INBX : 23.60 (-3.83%)
JMP Securities Thinks Inhibrx’s Stock is Going to Recover

JMP Securities analyst Reni Benjamin reiterated a Buy rating on Inhibrx (INBX – Research Report) today and set a price target of $40.00. The company's shares closed last Tuesday at $13.78, close to its...

INBX : 23.60 (-3.83%)
Inhibrx, Inc. (INBX) Reports Q1 Loss, Misses Revenue Estimates

Inhibrx, Inc. (INBX) delivered earnings and revenue surprises of -29.03% and 7.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

INBX : 23.60 (-3.83%)
RNA : 19.57 (+1.29%)
Cara Therapeutics (CARA) Reports Q1 Loss, Lags Revenue Estimates

Cara (CARA) delivered earnings and revenue surprises of 7.14% and 69.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

CARA : 12.56 (+6.35%)
INBX : 23.60 (-3.83%)
KaloBios Pharmaceuticals Inc. (HGEN) Reports Q1 Loss, Misses Revenue Estimates

KaloBios Pharmaceuticals Inc. (HGEN) delivered earnings and revenue surprises of 34.69% and 0.39%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

HGEN : 0.3619 (+3.37%)
INBX : 23.60 (-3.83%)
Inhibrx, Inc. (INBX) Soars 15%: Is Further Upside Left in the Stock?

Inhibrx, Inc. (INBX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase...

INBX : 23.60 (-3.83%)
CRMD : 3.38 (+5.63%)
Oversold Conditions For Inhibrx (INBX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

INBX : 23.60 (-3.83%)
Oversold Conditions For Inhibrx (INBX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

INBX : 23.60 (-3.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Inhibrx Inc. is a clinical-stage biotechnology company. The company's pipeline is focused on oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 27.72
2nd Resistance Point 26.51
1st Resistance Point 25.06
Last Price 23.60
1st Support Level 22.40
2nd Support Level 21.19
3rd Support Level 19.74

See More

52-Week High 47.90
Fibonacci 61.8% 32.53
Fibonacci 50% 27.78
Last Price 23.60
Fibonacci 38.2% 23.04
52-Week Low 7.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar